Stay updated on BLASST-1: Nivolumab Combo in MIBC Clinical Trial

Sign up to get notified when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0, indicating a new release with potentially significant changes from the previous version v2.9.7.
    Difference
    0.3%
    Check dated 2024-07-23T14:08:41.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T06:30:48.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the web page.
    Difference
    0.1%
    Check dated 2024-07-02T13:34:38.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-06-27T09:35:10.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the web page.
    Difference
    0.1%
    Check dated 2024-06-26T08:30:23.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value 'Show more Revision: v2.9.0' has been updated to 'MedlinePlus Genetics related topics: Bladder cancer MedlinePlus related topics: Bladder Cancer Drug Information available for: Cisplatin Gemcitabine Gemcitabine hydrochloride Nivolumab FDA Drug and Device Resources'. This change reflects an update in the information provided on the webpage regarding genetics related topics, drug information, and FDA resources related to bladder cancer treatment.
    Difference
    30%
    Check dated 2024-06-25T08:13:04.000Z thumbnail image

Stay in the know with updates to BLASST-1: Nivolumab Combo in MIBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.